Literature DB >> 10548570

Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

A Essig1, U Simnacher, M Susa, R Marre.   

Abstract

Chlamydia pneumoniae is a widely spread agent of respiratory tract infections in humans. A reliable serodiagnosis of the disease is hampered by the poor knowledge about immunodominant antigens in C. pneumoniae infections. We applied a novel strategy to identify immunogenic proteins of C. pneumoniae TW183 combining metabolic radiolabeling of de novo-synthesized chlamydial antigens with immunoprecipitation. By this technique C. pneumoniae antigens of approximately 160, 97 to 99, 60 to 62, 40, 27, and 15 kDa were detected in the vast majority of sera from patients with a current C. pneumoniae infection. By immunoblotting purified elementary bodies of C. pneumoniae TW183 with the same sera, only the 60- to 62-kDa antigen could be detected consistently. Sequential immunoprecipitation performed at different stages of the chlamydial developmental cycle revealed that the 60- to 62-kDa antigen is strongly upregulated after 24 to 48 h of host cell infection and is presented as a major immunogen in both C. pneumoniae-infected patients and mice. We conclude that, due to its high sensitivity and concurrent preservation of conformational epitopes, metabolic radiolabeling of chlamydial antigens combined with immunoprecipitation may be a useful method to reveal important immunogens in respiratory C. pneumoniae infection which might have been missed by immunoblot analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548570      PMCID: PMC95782          DOI: 10.1128/CDLI.6.6.819-825.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  45 in total

1.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Antigenic and molecular analyses of different Chlamydia pneumoniae strains.

Authors:  C A Jantos; S Heck; R Roggendorf; M Sen-Gupta; J H Hegemann
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line.

Authors:  M Heinemann; M Susa; U Simnacher; R Marre; A Essig
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.

Authors:  J Boman; A Allard; K Persson; M Lundborg; P Juto; G Wadell
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection.

Authors:  A Kutlin; N Tsumura; U Emre; P M Roblin; M R Hammerschlag
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

8.  Antibody response to Chlamydia pneumoniae infection in children with respiratory illness.

Authors:  A Kutlin; P M Roblin; M R Hammerschlag
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

9.  Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae.

Authors:  E M Peterson; X Cheng; Z Qu; L M de La Maza
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 10.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

View more
  7 in total

1.  Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR.

Authors:  U Reischl; N Lehn; U Simnacher; R Marre; A Essig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-24       Impact factor: 3.267

2.  Defining species-specific immunodominant B cell epitopes for molecular serology of Chlamydia species.

Authors:  K Shamsur Rahman; Erfan U Chowdhury; Anil Poudel; Anke Ruettger; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

3.  Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.

Authors:  K Wolf; E Fischer; D Mead; G Zhong; R Peeling; B Whitmire; H D Caldwell
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.

Authors:  Eric L Marston; Andrea V James; J Todd Parker; John C Hart; Teresa M Brown; Trudy O Messmer; Danny L Jue; Carolyn M Black; George M Carlone; Edwin W Ades; Jacquelyn Sampson
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Authors:  Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.

Authors:  Marcus Klein; Arne Kötz; Katussevani Bernardo; Martin Krönke
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Profiling antibody responses to infections by Chlamydia abortus enables identification of potential virulence factors and candidates for serodiagnosis.

Authors:  Vera Forsbach-Birk; Corinna Foddis; Ulrike Simnacher; Max Wilkat; David Longbottom; Gernot Walder; Christiane Benesch; Martin Ganter; Konrad Sachse; Andreas Essig
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.